Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (First Line) | Decision Base | US | 2015

What Key Attributes Do Oncologists and Payers Believe Will Differentiate Emerging Therapies?

The first-line chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) market is becoming increasingly crowded. In recent years, several new, high-priced therapies have been approved for use in this patient population, making this lucrative market more dynamic and competitive. The launch of ibrutinib (Johnson & Johnson/Janssen/Pharmacyclics’ Imbruvica) and idelalisib (Gilead Sciences’ Zydelig) in 2014 transformed the treatment algorithm and improved the outlook for patients. Nevertheless, clinical and commercial opportunity awaits emerging therapies that can provide greater survival benefits than the current standards of care and add minimal toxicities to the existing chemotherapy regimens used to treat first-line CLL/SLL.

Contact sales account_box

Hodgkin’s Lymphoma US 2015

Report

Venous Thromboembolism – Current Treatment – Treatment Algorithms: Claims Data Analysis – Venous Thromboembolism (US)

Venous thromboembolism (VTE) is the obstruction of a vein caused by a thrombus, described as deep vein thrombosis (DVT) or pulmonary embolism (PE), depending on the vein affected. Anticoagulants…

north_east

Report

Asthma – Current Treatment – Treatment Algorithms: Claims Data Analysis – Adult Asthma (US)

Two types of pharmacotherapies are used in parallel to treat adult asthma: rescue drugs and maintenance therapies. Rescue drugs are inhaled therapies that treat the acute symptoms of asthma via…

north_east

Report

Attention-Deficit-Hyperactivity Disorder – Current Treatment – Treatment Algorithms: Claims Data Analysis – Adult ADHD (US)

Attention-deficit / hyperactivity disorder (ADHD), a common childhood neurodevelopmental condition that can persist into adulthood, affects about 6% of U.S. adults, or approximately 15.5 million…

north_east

Report

Cystic Fibrosis – Unmet Need – Unmet Need – Cystic Fibrosis (US EU)

Cystic fibrosis (CF) is a genetic disease associated with more than 2,000 mutations identified in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These mutations cause aberrant…

north_east

Report

Hyperkalemia – Current Treatment – Treatment Algorithms: Claims Data Analysis – Hyperkalemia (US)

Hyperkalemia is defined as a serum potassium level above 5.0 mEq/L. This report covers the management of chronic hyperkalemia through diuretic therapy, correcting metabolic acidosis when present,…

north_east

Product logins

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (First Line) | Decision Base | US | 2015

Related Market Assessment Reports

Venous Thromboembolism – Current Treatment – Treatment Algorithms: Claims Data Analysis – Venous Thromboembolism (US)

Asthma – Current Treatment – Treatment Algorithms: Claims Data Analysis – Adult Asthma (US)

Attention-Deficit-Hyperactivity Disorder – Current Treatment – Treatment Algorithms: Claims Data Analysis – Adult ADHD (US)

Cystic Fibrosis – Unmet Need – Unmet Need – Cystic Fibrosis (US EU)

Hyperkalemia – Current Treatment – Treatment Algorithms: Claims Data Analysis – Hyperkalemia (US)

Follow us

Contact us